New prescription hypnotic for insomnia now available in CanadaFirst marketed orexin receptor antagonist is approved for adults with difficulties in falling asleep and/or maintaining sleep. Managing people with opioid-use disorder in the emergency departmentCanadian Association of Emergency Physicians offers recommendations for emergency healthcare providers to help address Canada’s opioid crisis. Nonbenzodiazepine hypnotic, Lunesta (eszopiclone) now marketed in Canada Approved for short-term use in adults with difficulty falling asleep, or nocturnal or early morning awakenings. Provide families with guidance on how to reset sleep times disrupted by COVID-19 Pandemic has significantly altered normal sleep patterns for children and teenagers Scientists get closer to blood test for Alzheimer's disease The testing identified people with Alzheimer's vs. no dementia or other types of it with accuracy ranging from 89% to 98% Spravato, a new intranasal treatment for resistant depression Intended for patients who have not responded adequately to at least two different antidepressants Consider long-acting injectable antipsychotics more often in early-phase schizophrenia Study reports significant delay in time to hospitalization compared to usual care when LAIAs are used in patients with early-phase schizophrenia Q&A: Antidepressants now Psychiatrist Dr. Jon Davine’s advice for FPs on optimizing antidepressant dose, switching and augmenting Overdiagnosed, overtreated For decades psychiatrists have argued over the boundaries between pathology and normality. Are we any closer to an answer? Beyond the baby blues How pharmacists can help women struggling with postpartum depression First Previous 26 27 28 29 30 Next Last
